The Three-Year Outcome Of Infliximab (Ifx), An Anti-Tnf-Alpha Antibody, In Patients With Refractory Intestinal-Behcet'S Disease (Bd)
ANNALS OF THE RHEUMATIC DISEASES(2014)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF THE RHEUMATIC DISEASES(2014)